You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TNBC

Showing 1 - 25 of 635
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • A1:SG with SHR3680
  • +7 more
  • (no location specified)
Jun 23, 2023

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • (no location specified)
Aug 4, 2022

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

    Not yet recruiting
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 22, 2022

    TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Alkaline Glucosodiene Molecules
    • (no location specified)
    Jul 14, 2023

    Metastatic Triple-negative Breast Cancer Trial in Italy (Tissue Immune Profile)

    Recruiting
    • Metastatic Triple-negative Breast Cancer
    • Tissue Immune Profile
    • Prato, FI, Italy
    • +6 more
    Apr 14, 2023

    Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Pembrolizumab 25 mg/ml
    • Paclitaxel injection
    • (no location specified)
    Oct 11, 2023

    Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

    Recruiting
    • Triple Negative Breast Cancer
    • HER2-negative Breast Cancer
    • HER2 - primed Dendritic cells
    • HER3 - primed Dendritic cells
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 10, 2023

    Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Atezolizumab + RP1
    • Paris, France
      Institut Curie
    Oct 2, 2023

    TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Nov 5, 2023

    Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

    Not yet recruiting
    • Breast Neoplasm
    • (no location specified)
    May 8, 2023

    Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

    Recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Fairway, Kansas
    • +5 more
    Jan 26, 2023

    Epidemiology of TNBC in Asyut Clinical Oncology Department

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Oct 15, 2022

      Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Residual Disease
      • (no location specified)
      Nov 15, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • (no location specified)
      Jun 11, 2023

      Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

      Withdrawn
      • Triple Negative Breast Cancer (TNBC)
      • El Segundo, California
        Chan Soon-Shiong Institute for Medicine
      Mar 28, 2022

      Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

      Recruiting
      • Breast Cancer
      • +9 more
      • Boston, Massachusetts
      • +2 more
      Oct 25, 2022

      Brain Metastases, Tumor Trial in Houston (Pembrolizumab, Lenvatinib)

      Recruiting
      • Brain Metastases
      • Tumor
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 8, 2022

      Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Jul 6, 2022

      TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • (no location specified)
      May 8, 2023